- Previous Close
0.0900 - Open
0.0900 - Bid 0.0800 x --
- Ask 0.0850 x --
- Day's Range
0.0800 - 0.0900 - 52 Week Range
0.0800 - 0.2812 - Volume
51,762 - Avg. Volume
115,563 - Market Cap (intraday)
20.301M - Beta (5Y Monthly) 3.16
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1700 - Earnings Date Jun 24, 2025 - Jun 30, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Burcon NutraScience Corporation, together with its subsidiaries, develops plant proteins and ingredients for use in the food and beverage industries in Canada. The company offers Peazazz and Peazac, a pea protein for use in dairy alternatives, ready-to-drink beverages, dry blended beverages, bars, baked goods, and meat substitute products; Puratein, a canola protein isolate use for meat alternatives, such as burgers, sausages, and nutrition bars; and Supertein, a canola protein for use in non-dairy frozen desserts, egg alternative, plant-based marshmallows, and ready-to-mix beverages, whipped toppings, and plant-based bars. It also provides Nutratein, a canola protein comprising a mixture of globulin and albumin proteins for use in meat and egg alternatives, and other plant-based functional foods; and CLARISOY, a soy protein for use in sports nutrition beverages, citrus-based drinks, fruit-flavored beverages, lemonades, powdered beverage mixes, and non-beverage plant-based products. In addition, the company offers hemp protein isolates. The company was formerly known as Burcon Capital Corp. and changed its name to Burcon NutraScience Corporation in October 1999. The company was incorporated in 1998 and is headquartered in Vancouver, Canada.
www.burcon.caRecent News: BU.TO
View MorePerformance Overview: BU.TO
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BU.TO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BU.TO
View MoreValuation Measures
Market Cap
22.84M
Enterprise Value
24.55M
Trailing P/E
--
Forward P/E
4.50
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
44.01
Price/Book (mrq)
3.94
Enterprise Value/Revenue
89.79
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-54.84%
Return on Equity (ttm)
-597.23%
Revenue (ttm)
338.57k
Net Income Avi to Common (ttm)
-8.08M
Diluted EPS (ttm)
-0.1700
Balance Sheet and Cash Flow
Total Cash (mrq)
591.02k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-3.83M